Bihui Li, Bihui Li, Xing Zhang, Qianyao Ren, Li Gao, & Jing Tian. (2022). NVP-BEZ235 Inhibits Renal Cell Carcinoma by Targeting TAK1 and PI3K/Akt/mTOR Pathways. Frontiers Media S.A..
Chicago Style (17th ed.) CitationBihui Li, Bihui Li, Xing Zhang, Qianyao Ren, Li Gao, and Jing Tian. NVP-BEZ235 Inhibits Renal Cell Carcinoma by Targeting TAK1 and PI3K/Akt/mTOR Pathways. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationBihui Li, et al. NVP-BEZ235 Inhibits Renal Cell Carcinoma by Targeting TAK1 and PI3K/Akt/mTOR Pathways. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.